| Christopher J Holewinski, RP, DO | |
|
800 Mercy Dr, Council Bluffs, IA 51503-3128 | |
| (712) 328-5490 | |
| (712) 325-2499 |
| Full Name | Christopher J Holewinski |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 14 Years |
| Location | 800 Mercy Dr, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043643687 | NPI | - | NPPES |
| 1043643687 | Other | IA | WELLMARK |
| 1043643687 | Other | NE | BC/BS NE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health Mercy Council Bluffs | Council bluffs, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alegent Creighton Clinic | 1951210418 | 827 |
News Archive
The Alzheimer's Foundation of America issued this statement today regarding passage of the National Alzheimer's Project Act. The National Alzheimer's Project Act would create the National Alzheimer's Project, which would coordinate government efforts to prevent and treat the disease and create a national strategy for defeating Alzheimer's disease.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.
Boston Scientific Corporation today announced that it is voluntarily recalling all of its iCross Coronary Imaging Catheters used in intravascular ultrasound imaging in patients who are candidates for transluminal coronary interventional procedures.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 4 days ago
| Entity Name | Alegent Creighton Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598811069 PECOS PAC ID: 1951210418 Enrollment ID: O20040116000817 |
News Archive
The Alzheimer's Foundation of America issued this statement today regarding passage of the National Alzheimer's Project Act. The National Alzheimer's Project Act would create the National Alzheimer's Project, which would coordinate government efforts to prevent and treat the disease and create a national strategy for defeating Alzheimer's disease.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.
Boston Scientific Corporation today announced that it is voluntarily recalling all of its iCross Coronary Imaging Catheters used in intravascular ultrasound imaging in patients who are candidates for transluminal coronary interventional procedures.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher J Holewinski, RP, DO 800 Mercy Dr, Council Bluffs, IA 51503-3128 Ph: (855) 524-4001 | Christopher J Holewinski, RP, DO 800 Mercy Dr, Council Bluffs, IA 51503-3128 Ph: (712) 328-5490 |
News Archive
The Alzheimer's Foundation of America issued this statement today regarding passage of the National Alzheimer's Project Act. The National Alzheimer's Project Act would create the National Alzheimer's Project, which would coordinate government efforts to prevent and treat the disease and create a national strategy for defeating Alzheimer's disease.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
The National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH), disclosed results from an interim analysis of the AIM-HIGH clinical trial.
Boston Scientific Corporation today announced that it is voluntarily recalling all of its iCross Coronary Imaging Catheters used in intravascular ultrasound imaging in patients who are candidates for transluminal coronary interventional procedures.
Sigma-Aldrich Corporation today announced that the Cerilliant® brand within its Applied Diagnostics and Testing business segment now offers the first-ever reference solutions for qualitative evaluation of drug interferences in a testing laboratory's analytical methods.
› Verified 4 days ago
Dr. Mohammed Zalabani, MBCHB Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 855-524-4001 Fax: 712-325-2499 | |
Worku Haile, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 855-524-4001 Fax: 712-325-2499 | |
Nicholas Sakis, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 855-524-4001 Fax: 712-325-2249 |